Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOLECULAR TESTING OF CANCER BY INTEGRATED GENOMIC, TRANSCRIPTOMIC, AND PROTEOMIC ANALYSIS

NCT02213822 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT02213822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOLECULAR TESTING OF CANCER BY INTEGRATED GENOMIC, TRANSCRIPTOMIC, AND PROTEOMIC ANALYSIS
Lead sponsor
Rhode Island Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2013
Completion date
August 31, 2015
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies, solid tumors